Eugene

[email protected]

LATEST

Catalent Completes $5.5 Million Expansion of Clinical Storage Capacity
By

By
Catalent Pharma Solutions has completed a $5.5-million expansion at its more than 200,000-square-foot site Philadelphia, Pennsylvania to provide additional clinical packaging and storage capacity. The facility is one of the…

Selexis Invests $2 Million in Cell-Line Development
By

By
Selexis, a Geneva, Switzerland-based provider of mammalian cell-line generation technology, has purchased, installed and invested $2 million in new laboratory equipment as well as hired new employees and signed its…

Sartorius Stedim Biotech, Penn State University Partner
By

By
Sartorius Stedim Biotech, a Goettingen, Germany-headquartered supplier for the biopharmaceutical industry, and Penn State University have partnered to advance multidisciplinary teaching and research in biotechnology. Part of Sartorius’ investment will…

FDA Issues Final Guidance To Advance Policies for Drug-Development Process
By

By
The US Food and Drug Administration (FDA) has finalized a guidance, Special Protocol Assessment Guidance for Industry, which provides drug manufacturers with information about the procedures and policies adopted by…

EMA Redistributes UK Centralized Authorized Products in Anticipation of Brexit
By

By
The European Medicines Agency (EMA) has reallocated the medicines for the UK’s portfolio of centrally authorized products in anticipation of Brexit, the UK’s withdrawal from the European Union (EU). Over…

BI, Lilly To Test Diabetes Drug Jardiance in Kidney Disease
By

By
Boehringer Ingelheim (BI) and Eli Lilly and Company have partnered in an academic collaboration with the University of Oxford to investigate the effects of the companies’ diabetes drug, Jardiance (empagliflozin),…

GSK Transfers Rare-Disease Gene Therapy Portfolio to Orchid Therapeutics; Takes Equity Stake
By

By
GlaxoSmithKline (GSK) has agreed to transfer its portfolio of approved and investigational rare-disease gene therapies to Orchard Therapeutics, a Foster City, California-based clinical-stage biotechnology company. Under the agreement, GSK will…

Shire To Sell Oncology Business to Servier for $2.4 Billion
By

By
Shire has agreed to sell its oncology business to Servier, a Suresnes, France-based pharmaceutical company, for $2.4 billion. Shire’s oncology business includes in-market products, Oncaspar (pegaspargase), a component of a…

MilliporeSigma Introduces New Single-use Technologies for Biomfg
By

By
MilliporeSigma has introduced three new products to support flexible manufacturing of biologics. The products include the following: Pellicon Capsule with Ultracel Membrane, a single-use tangential flow filtration device; Millipak Final…

Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility
By

By
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients, has installed multiple continuous flow reactor platforms at its High Point, North Carolina facility. The investment aims…